DBIA
GILD icon

Dumont & Blake Investment Advisors’s Gilead Sciences GILD Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,255
Closed -$270K – 159
2014
Q2 		$270K Buy
3,255
+255
+9% +$19.8K 0.14% 134
2014
Q1 		$213K Buy
+3,000
New +$235K 0.11% 137

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dumont & Blake Investment Advisors's GILD Position: Q3 2014 in Review

Dumont & Blake Investment Advisors sold out of Gilead Sciences (GILD) in Q3 2014, closing a stake of 3,255 shares — an estimated $270K sold.

Dumont & Blake Investment Advisors first reported a position in GILD in Q1 2014 and held it in 2 quarters. The position peaked at $270K in Q2 2014. 1,326 funds tracked by Wall St. Rank hold GILD as of Q3 2014.

  • Dumont & Blake Investment Advisors reported no remaining Gilead Sciences position as of Q3 2014 after selling out during the quarter.
  • Dumont & Blake Investment Advisors sold 3,255 Gilead Sciences shares in Q3 2014, an estimated $270K.
  • Dumont & Blake Investment Advisors first reported a position in Gilead Sciences in Q1 2014 and held it in 2 quarters.
  • Dumont & Blake Investment Advisors's Gilead Sciences position peaked at $270K in Q2 2014.
  • 1,326 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2014.

Based on Dumont & Blake Investment Advisors's 13F filing for Q3 2014, filed 28 Oct 2014.